Colorectal Cancer Trial, Recruiting (NCT06136949)

Colorectal Cancer Trial, Recruiting NCT06136949 Sponsor: Centro di Riferimento Oncologico - Aviano Condition: Colorectal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06136949 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Colorectal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with colorectal cancer (cancer of the colon or rectum), confirmed through laboratory testing of tissue, at any stage of the disease
People aged 18 years or older
People who are willing and able to sign a consent form agreeing to take part
People who have tissue and blood samples already stored at the institution's biological sample bank (biobank) that can be used for research

Who may not be able to join:

People where the process of collecting and storing tumour samples for the biobank could interfere with the tests needed to diagnose or assess their cancer
People who are currently pregnant or breastfeeding
People who have had another type of cancer in the past 5 years — though exceptions may apply for certain skin cancers that were adequately treated, or early-stage cervical cancer that was fully removed by surgery (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vincenzo Canzonieri, MD,PhD, Centro di Riferimento Oncologico di Aviano (CRO) - IRCCS

Phone: 0434 659 618

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06136949

Sponsor: Centro di Riferimento Oncologico - Aviano

Phase: Not Applicable

Status: Recruiting

Condition: Colorectal Cancer

Trial contact: 0434 659 618

More information: https://clinicaltrials.gov/study/NCT06136949

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with colorectal cancer (cancer of the colon or rectum), confirmed through laboratory testing of tissue, at any stage of the disease
People aged 18 years or older
People who are willing and able to sign a consent form agreeing to take part
People who have tissue and blood samples already stored at the institution's biological sample bank (biobank) that can be used for research

Who may not be able to join:

People where the process of collecting and storing tumour samples for the biobank could interfere with the tests needed to diagnose or assess their cancer
People who are currently pregnant or breastfeeding
People who have had another type of cancer in the past 5 years — though exceptions may apply for certain skin cancers that were adequately treated, or early-stage cervical cancer that was fully removed by surgery (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centro di Riferimento Oncologico - Aviano

Registry

ClinicalTrials.gov

Start date

22 May 2023

Est. completion

31 December 2032

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Frequency of overexpression of STARD3 in both early and advanced CRC patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov